2014
DOI: 10.1164/rccm.201312-2121le
|View full text |Cite
|
Sign up to set email alerts
|

Plasma Complement Levels Are Associated with Primary Graft Dysfunction and Mortality after Lung Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
28
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 28 publications
(30 citation statements)
references
References 12 publications
0
28
0
Order By: Relevance
“…This difference is consistent with the hypothesis that PGD is linked to tissue viability or immune activation that may restrict TTV levels in the lung. PGD is associated with activation of multiple innate immune responses (1517) which might control TTV but also mediate injury contributing to PGD. Alternatively, in addition to immune cells, TTV has also been reported to replicate in respiratory epithelia and lung tissue (65, 66).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This difference is consistent with the hypothesis that PGD is linked to tissue viability or immune activation that may restrict TTV levels in the lung. PGD is associated with activation of multiple innate immune responses (1517) which might control TTV but also mediate injury contributing to PGD. Alternatively, in addition to immune cells, TTV has also been reported to replicate in respiratory epithelia and lung tissue (65, 66).…”
Section: Discussionmentioning
confidence: 99%
“…Host genetic variation in genes involved in oxidant stress responses and innate immunity correlate with risk of PGD (13, 14). PGD has also been associated with inflammasome activation, pattern recognition receptor signaling, and complement activation within the allograft (1517). These studies raise the possibility of a microbial contribution to pathogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…Circulating levels of the anti-coagulant protein C are lower in those with PGD compared to those without PGD while levels of the pro-inflammatory protein plasminogen activator inhibitor-1 (PAI-1) are higher in those with PGD 21 . Changes in plasma levels of complement protein 5a (C5a), a potent neutrophil and lymphocyte chemoattractant, are associated with PGD after transplant 22 . Plasma levels of these proteins are also excellent predictors of obesity, with PAI-1 being one of the top 5 circulating biochemical predictors of total, abdominal, visceral and liver fat 23 .…”
Section: Discussionmentioning
confidence: 99%
“…A variety of clinical risk factors for PGD have been identified with contributions from the donor (3)(4)(5)(6)(7), the recipient (3)(4)(5)(7)(8)(9)(10), and operative variables (4,5,8,11). In addition, a number of biomarkers have been associated with increased risk of PGD, including markers of innate and adaptive immune activation, epithelial and endothelial injury, coagulation, vascular permeability, and lipid peroxidation (2,(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27). Despite identification of these clinical and biomarker predictors of PGD, the mechanisms leading to PGD are not well understood, and there are no specific therapeutic interventions for PGD.…”
Section: Introductionmentioning
confidence: 99%